Delivery Order SPE2DB20D2104-SPE2DB22FS01X
- Not listed
- This is a federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., by the Defense Logistics Agency (DLA). The $1,772.20 fixed-price delivery order is for the supply of 1,000 tablets of the pharmaceutical drug Mirtazapine 30 mg. The contract has an ultimate completion date of April 28, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026....
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,053.26 firm fixed-price delivery order is for the supply of 4,555,552,160 units of Mirtazapine 15 mg tablets. The contract has an ultimate completion date of December 1, 2021 and is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,089.89, is for the delivery of 4,563,718,136 tablets of the medication mirtazapine 30 mg, with a completion date of February 22, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA...
- This federal contract award, with ID SPE2DB22D3102|SPE2DB24FK8RL, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The $1,748.61 firm fixed-price delivery order is for the supply of 4,562,525,432 units of the prescription medication Mirtazapine 30 mg tablets. The contract has an ultimate completion date of October 19, 2023 and was awarded on October 18, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,480.83, is for the delivery of Mirtazapine 30 mg tablets in 1,000-count packages. The contract is a Firm Fixed Price Delivery Order that runs through January 4, 2024. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,144.24 Firm Fixed Price delivery order is for the supply of 4,554,483,108 units of Mirtazapine 30mg tablets. The award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen Drug Corp holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November...
- This federal contract award, valued at $3,212.59, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of 4,566,528,079 units of 30 mg Mirtazapine tablets, a mental health treatment medication. The contract has a Firm Fixed Price pricing type and an ultimate completion date of November 25, 2024. This award is not associated with a set-aside...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,481.93 firm-fixed-price delivery order is for the supply of 4,555,833 units of the prescription medication mirtazapine 15 mg tablets. The contract has an ultimate completion date of January 5, 2022 and was awarded on January 4, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc.,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Mirtazapine 7.5 mg tablets. The $2,281.84 firm-fixed-price delivery order is a part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a...
- This federal contract award, with ID SPE2DB20D1004|SPE2DB24FE9R2, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,230.61 firm-fixed-price delivery order contract is for the supply of 4562953258 - Mirtazapine 7.5 mg tablets in 30-count packages. The contract has an ultimate completion date of December 1, 2023 and was awarded on November 30, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB22FS01XDelivery Order
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $2,738.95 firm fixed-price delivery order is for the supply of 4,556,496,560 units of the pharmaceutical drug mirtazapine 30 mg tablets. The award has an ultimate completion date of March 9, 2022 and was made on March 8, 2022. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract award did not use any set-aside designations, indicating open competition. Amerisourcebergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 3/8/22 |